Top Markets
Coin of the day
Myovant Sciences Ltd. Myovant Sciences Ltd.

Myovant Sciences Ltd.

MYOV
Classement en actions #5525
Myovant Sciences Ltd. is a biopharmaceutical company focused on innovating... Myovant Sciences Ltd. is a biopharmaceutical company focused on innovating healthcare solutions for both women and men. Its flagship product is relugolix, an orally administered, once-daily small molecule that functions as a gonadotropin-releasing hormone (GnRH) receptor antagonist. This medication is indicated for conditions such as heavy menstrual bleeding caused by uterine fibroids, pain associated with endometriosis, and advanced prostate cancer. The company is also developing MVT-602, an oligopeptide kisspeptin agonist, currently in Phase II clinical trials for treating female infertility within assisted reproductive procedures. Myovant collaborates with Pfizer Inc. for the development and commercialization of relugolix across oncology and women's health sectors. Incorporated in 2016, initially as Roivant Endocrinology Ltd. before rebranding to Myovant Sciences Ltd. in May of that year, the firm is based in London, United Kingdom, and operates as a subsidiary of Sumitovant Biopharma Ltd.
Prix de l'action
$26.98
Dernière synchronisation: 2023-03-09
Capitalisation boursière
$2.62B
Changement (1 jour)
-0.04%
Changement (1 an)
0.00%
Pays
GB
Échange Myovant Sciences Ltd. (MYOV)

Catégorie

Historique du prix de l'action pour Myovant Sciences Ltd. (MYOV)
Prix de clôture le plus élevé : $26.97 le 2023-03-01

Prix de clôture le plus bas : $12.79 le 2016-10-01
Historique du prix de l'action de Myovant Sciences Ltd. de 2016 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 0.28%
2022 73.07%
2021 -37.07%
2020 50.47%
2019 -4.83%
2018 41.15%
2017 8.58%
2016 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$549.38 41.20%
US
$1.05K 47.75%
NL
$148.35 491.02%
US
$122.63 -12.65%
AU
$763.69 6.97%
CH